98%
921
2 minutes
20
A total of 4006 tropical and subtropical rice germplasms were screened for brown planthopper resistance, and the resistance mechanisms of 63 highly resistant accessions were characterized. This led to the designation of three novel resistance QTLs: Bph47, Bph48, and Bph49. The brown planthopper (BPH) is a significant piercing-sucking pest of rice plants that causes widespread destruction globally. Discovering new germplasms and genes for BPH resistance is essential for enhancing genetic diversity in rice breeding. In this study, 4006 rice accessions from tropical and subtropical regions were screened for BPH resistance at the seedling stage, and 63 accessions with high-resistant were identified. Of these, 59 accessions exhibited high resistance to BPH at the adult stage. The 63 accessions displayed widespread variation in key agronomic traits, though most were generally unsatisfactory. Assessments of antixenosis, antibiosis, and tolerance indicated diverse resistance mechanisms in the 63 accessions, with the majority (39/63) demonstrating both antixenosis and antibiosis. Microscopic observations and physiological assessments revealed significant differences in vascular bundle structure, fiber content, and activity of defense-related enzymes between the 63 high-resistance and 27 susceptible ones. Furthermore, correlation analysis highlighted a substantial positive relationship between BPH resistance and parameters such as rice trypsin inhibitor (RTI) levels and width of the sclerenchyma layer (WSL). Genetic analysis of F segregating populations from four resistant accessions crossed with the susceptible rice variety 9311 identified three novel major-effect quantitative-trait loci (QTLs) located on chromosome 1L (690 kb and 1.84 Mb) and 5S (295 kb). This study significantly enriched the BPH-resistant germplasm sources and genes, highlighting the varied resistance mechanisms of rice against BPH.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00122-025-04839-6 | DOI Listing |
Mol Cancer Ther
September 2025
Case Western Reserve University School of Medicine, Cleveland, OH, United States.
The estrogen receptor (ER or ERα) remains the primary therapeutic target for luminal breast cancer, with current treatments centered on competitive antagonists, receptor down-regulators, and aromatase inhibitors. Despite these options, resistance frequently emerges, highlighting the need for alternative targeting strategies. We discovered a novel mechanism of ER inhibition that targets the previously unexplored interface between the DNA-binding domain (DBD) and ligand-binding domain (LBD) of the receptor.
View Article and Find Full Text PDFNanoscale
September 2025
Institute of Health Innovation & Technology, National University of Singapore, Singapore, 117599, Singapore.
The rapid increase in multidrug-resistant (MDR) bacteria and biofilm-associated infections has intensified the global need for innovative antimicrobial strategies. Phage therapy offers promising precision against MDR pathogens by utilizing the natural ability of phages to specifically infect and lyse bacteria. However, their clinical application is hampered by challenges such as narrow host range, immune clearance and limited efficacy within biofilms.
View Article and Find Full Text PDFFuture Oncol
September 2025
Department of General Surgery, Institute of General Surgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou University, Yangzhou, China.
Immune checkpoint therapy has demonstrated significant potential in the treatment of various solid tumors. Among these, tumor-induced immunosuppression mediated by programmed cell death protein 1 (PD-1) represents a critical checkpoint. PD-1/programmed death-ligand 1 (PD-L1) inhibitors have been proven to exhibit substantial efficacy in solid tumors such as melanoma and bladder cancer.
View Article and Find Full Text PDFPhys Chem Chem Phys
September 2025
School of Electrical and Automation Engineering, Suzhou University of Technology, Suzhou, 215506, China.
A flexible bipolarization conversion metasurface based on graphene is proposed in this paper, which can achieve single-band linear-to-linear (LTL) and dual-band linear-to-circular (LTC) polarization conversion. The polarization conversion ratio (PCR) and axial ratio (AR) are dynamically regulated by varying the sheet resistance () of graphene. When = 1400 Ω Sq, the designed metasurface achieves a single-band LTL polarization conversion of 7.
View Article and Find Full Text PDFCancer Biol Med
September 2025
Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410013, China.
Objective: Osimertinib (OSI) therapy, a cornerstone in treating non-small cell lung cancer (NSCLC), has been severely limited by rapidly developing acquired resistance. Inhibition of bypass activation using a combination strategy holds promise in overcoming this resistance. Biguanides, with excellent anti-tumor effects, have recently attracted much attention for this potential.
View Article and Find Full Text PDF